Cargando…
May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
Autores principales: | Spina Tensini, F., Spina Tensini, T., Franklin, G.L., Teive, H.A.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299859/ https://www.ncbi.nlm.nih.gov/pubmed/32575004 http://dx.doi.org/10.1016/j.parkreldis.2020.06.012 |
Ejemplares similares
-
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022) -
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
por: Dinoto, Alessandro, et al.
Publicado: (2022) -
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022) -
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022) -
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)